17-N-Allylamino-17-Demethoxygeldanamycin (17-AAG) in Treating Women With Refractory Locally Advanced or Metastatic Breast Cancer

This study has been completed.

Study NCT00096109 Information provided by National Cancer Institute (NCI)

First Received: November 9, 2004 Last Updated: November 7, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Primary Completion Date:	November 2009 (Final data collection date for primary outcome measure)